Release of soluble ligands for the activating NKG2D receptor: One more immune evasion strategy evolved by HIV-1?

Erica Giuliani, Lia Vassena, Cristina Cerboni, Margherita Doria

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Increasing lines of evidence indicate that NKG2D, an activating receptor of natural killer (NK) and CD8+ T cells, plays an important role in immune responses against HIV-1. Through its ability to recognize a diverse array of ligands (NKG2DLs) induced by cell ‘stress’ such as viral infection, NKG2D delivers activating and co-stimulatory signals resulting in cytotoxicity and release of cytokines. Therefore, HIV-1 and other viruses have evolved clever mechanisms to counteract NKG2Ddependent immune responses. While, on one hand, the HIV-1 Vpr protein up-regulates NKG2DLs expression by activating the DNA damage response (DDR) pathway, other viral proteins (Nef and Vif) have developed the capacity to reduce NKG2DLs expression levels. In addition, recent evidences suggest that HIV-1-infected CD4+ T cells may release NKG2DLs, particularly MICA, in soluble form, a phenomenon that has the potential to down-modulate NKG2D on circulating lymphocytes and allow evasion of NKG2D-mediated immune responses. Indeed, despite being controversial, lower NKG2D expression was found on both NK and CD8+ T cells in HIV-1-infected patients. This review discusses recent advances in the understanding of how HIV-1 affects the NKG2D/NKG2DLs system, with a special focus on virus-induced release of soluble NKG2DLs and its functional implications for the immune surveillance of the infected host.

Original languageEnglish
Pages (from-to)54-64
Number of pages11
JournalCurrent Drug Targets
Volume17
Issue number1
Publication statusPublished - 2016

Fingerprint

NK Cell Lectin-Like Receptor Subfamily K
Immune Evasion
T-cells
HIV-1
Ligands
Viruses
Natural Killer T-Cells
Lymphocytes
Viral Proteins
Cytotoxicity
Virus Release
Cytokines
Virus Diseases
DNA
DNA Damage
Up-Regulation
T-Lymphocytes

Keywords

  • HIV-1
  • MICA
  • MICB
  • NKG2D
  • Shedding
  • ULBP1-6

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Clinical Biochemistry
  • Molecular Medicine

Cite this

Release of soluble ligands for the activating NKG2D receptor : One more immune evasion strategy evolved by HIV-1? / Giuliani, Erica; Vassena, Lia; Cerboni, Cristina; Doria, Margherita.

In: Current Drug Targets, Vol. 17, No. 1, 2016, p. 54-64.

Research output: Contribution to journalArticle

@article{fbd0266d0aa2456b8fe5c007638c616c,
title = "Release of soluble ligands for the activating NKG2D receptor: One more immune evasion strategy evolved by HIV-1?",
abstract = "Increasing lines of evidence indicate that NKG2D, an activating receptor of natural killer (NK) and CD8+ T cells, plays an important role in immune responses against HIV-1. Through its ability to recognize a diverse array of ligands (NKG2DLs) induced by cell ‘stress’ such as viral infection, NKG2D delivers activating and co-stimulatory signals resulting in cytotoxicity and release of cytokines. Therefore, HIV-1 and other viruses have evolved clever mechanisms to counteract NKG2Ddependent immune responses. While, on one hand, the HIV-1 Vpr protein up-regulates NKG2DLs expression by activating the DNA damage response (DDR) pathway, other viral proteins (Nef and Vif) have developed the capacity to reduce NKG2DLs expression levels. In addition, recent evidences suggest that HIV-1-infected CD4+ T cells may release NKG2DLs, particularly MICA, in soluble form, a phenomenon that has the potential to down-modulate NKG2D on circulating lymphocytes and allow evasion of NKG2D-mediated immune responses. Indeed, despite being controversial, lower NKG2D expression was found on both NK and CD8+ T cells in HIV-1-infected patients. This review discusses recent advances in the understanding of how HIV-1 affects the NKG2D/NKG2DLs system, with a special focus on virus-induced release of soluble NKG2DLs and its functional implications for the immune surveillance of the infected host.",
keywords = "HIV-1, MICA, MICB, NKG2D, Shedding, ULBP1-6",
author = "Erica Giuliani and Lia Vassena and Cristina Cerboni and Margherita Doria",
year = "2016",
language = "English",
volume = "17",
pages = "54--64",
journal = "Current Drug Targets",
issn = "1389-4501",
publisher = "Bentham Science Publishers B.V.",
number = "1",

}

TY - JOUR

T1 - Release of soluble ligands for the activating NKG2D receptor

T2 - One more immune evasion strategy evolved by HIV-1?

AU - Giuliani, Erica

AU - Vassena, Lia

AU - Cerboni, Cristina

AU - Doria, Margherita

PY - 2016

Y1 - 2016

N2 - Increasing lines of evidence indicate that NKG2D, an activating receptor of natural killer (NK) and CD8+ T cells, plays an important role in immune responses against HIV-1. Through its ability to recognize a diverse array of ligands (NKG2DLs) induced by cell ‘stress’ such as viral infection, NKG2D delivers activating and co-stimulatory signals resulting in cytotoxicity and release of cytokines. Therefore, HIV-1 and other viruses have evolved clever mechanisms to counteract NKG2Ddependent immune responses. While, on one hand, the HIV-1 Vpr protein up-regulates NKG2DLs expression by activating the DNA damage response (DDR) pathway, other viral proteins (Nef and Vif) have developed the capacity to reduce NKG2DLs expression levels. In addition, recent evidences suggest that HIV-1-infected CD4+ T cells may release NKG2DLs, particularly MICA, in soluble form, a phenomenon that has the potential to down-modulate NKG2D on circulating lymphocytes and allow evasion of NKG2D-mediated immune responses. Indeed, despite being controversial, lower NKG2D expression was found on both NK and CD8+ T cells in HIV-1-infected patients. This review discusses recent advances in the understanding of how HIV-1 affects the NKG2D/NKG2DLs system, with a special focus on virus-induced release of soluble NKG2DLs and its functional implications for the immune surveillance of the infected host.

AB - Increasing lines of evidence indicate that NKG2D, an activating receptor of natural killer (NK) and CD8+ T cells, plays an important role in immune responses against HIV-1. Through its ability to recognize a diverse array of ligands (NKG2DLs) induced by cell ‘stress’ such as viral infection, NKG2D delivers activating and co-stimulatory signals resulting in cytotoxicity and release of cytokines. Therefore, HIV-1 and other viruses have evolved clever mechanisms to counteract NKG2Ddependent immune responses. While, on one hand, the HIV-1 Vpr protein up-regulates NKG2DLs expression by activating the DNA damage response (DDR) pathway, other viral proteins (Nef and Vif) have developed the capacity to reduce NKG2DLs expression levels. In addition, recent evidences suggest that HIV-1-infected CD4+ T cells may release NKG2DLs, particularly MICA, in soluble form, a phenomenon that has the potential to down-modulate NKG2D on circulating lymphocytes and allow evasion of NKG2D-mediated immune responses. Indeed, despite being controversial, lower NKG2D expression was found on both NK and CD8+ T cells in HIV-1-infected patients. This review discusses recent advances in the understanding of how HIV-1 affects the NKG2D/NKG2DLs system, with a special focus on virus-induced release of soluble NKG2DLs and its functional implications for the immune surveillance of the infected host.

KW - HIV-1

KW - MICA

KW - MICB

KW - NKG2D

KW - Shedding

KW - ULBP1-6

UR - http://www.scopus.com/inward/record.url?scp=84952008356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952008356&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84952008356

VL - 17

SP - 54

EP - 64

JO - Current Drug Targets

JF - Current Drug Targets

SN - 1389-4501

IS - 1

ER -